Heart Failure Reviews

, Volume 1, Issue 4, pp 249–260 | Cite as

Sudden death in heart failure

  • J. Guindo
  • A. Bayés Genis
  • J. M. Dominguez de Rozas
  • M. Fiol
  • X. Vinolas
  • A. Bayés de Luna
Clinical Reviews

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brachmann J, Dietz R, Kübler W (eds). Heart Failure and Arrhythmias. Berlin, Springer-Verlag, 1990.Google Scholar
  2. 2.
    Barnett DB, Pouleur H, Francis S (eds). Congestive Heart Failure. Pathophysiology and Treatment. New York, Marcel Dekker, 1993.Google Scholar
  3. 3.
    Hosenpud JD, Greenberg BH. Congestive Heart Failure: Pathophysiology, Diagnosis and Comprehensive Approach to Management. New York, Springer-Verlag, 1994.Google Scholar
  4. 4.
    McFate W. Epidemiology of congestive heart failure. Am J Cardiol 1985;55:3A.Google Scholar
  5. 5.
    Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301.Google Scholar
  6. 6.
    Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham study. Am Heart J 1988; 115:869.Google Scholar
  7. 7.
    Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987;59:634.Google Scholar
  8. 8.
    Packer M. Sudden unexpected death in patients with congestive heart failure: A second frontier. Circulation 1985; 72:681.Google Scholar
  9. 9.
    Bigger JT. Why patients with congestive heart failure die: Arrhythmias and sudden cardiac death. Circulation 1987;75:IV-28.Google Scholar
  10. 10.
    Anderson KP, Freedman RA, Ason JW. Sudden death in idiopathic dilated myocardiopathy. Ann Intern Med 1987; 107:104.Google Scholar
  11. 11.
    Goldstein S, Bayés de Luna A, Guindo Soldevila J. Sudden Cardiac Death. Armonk, New York. Futura Publishing Company, Inc. 1994.Google Scholar
  12. 12.
    Maskin CS, Siskind SJ, LeJemtel TH. High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J 1984;107:896.Google Scholar
  13. 13.
    Sakurai T, Kawai C. Sudden death in idiopathic cardiomyopathy. Jpn Circ J 1983;47:581.Google Scholar
  14. 14.
    Massie B, Ports T, Chatterjee K, Parmley W, Ostland J, O'Young J, Haughom F. Long-term vasodilator therapy for heart failure: Clinical response and its relationship to hemodynamic measurements. Circulation 1981;63:269.Google Scholar
  15. 15.
    Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257.Google Scholar
  16. 16.
    Wilson JR, Schwartz JS, Sutton MS-J, Ferraro N, Horowitz LN, Reichek N, Josephson ME. Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983;2:403.Google Scholar
  17. 17.
    VonOlshausen K, Schafer A, Mehmel HC, Schwartz F, Senges J, Kubler W. Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 1984;51:195.Google Scholar
  18. 18.
    Franciosa JA, Wilen M, Ziesche SM, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831.Google Scholar
  19. 19.
    Huang SK, Messer JV, Denes P: Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients. Am J Cardiol 1983;51:507.Google Scholar
  20. 20.
    Francis GS: Development of arrhythmias in the patient with congestive heart failure: Pathophysiology, prevalence and prognosis. Am J Cardiol 1986;57:3B.Google Scholar
  21. 21.
    Chakko CS, Gheorghiade M: Ventricular arrhythmias in severe heart failure: Incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J 1985;109:497.Google Scholar
  22. 22.
    Meinertz T, Hofman T, Kasper W, Treese M, Bechtold H, Stienen U, Pop T, Leitner E-RV, Andersen D, Meyer J. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1984;53:902.Google Scholar
  23. 23.
    Holmes J, Kubo SH, Cody RJ, Kligfield P. Arrhythmias in ischemic and non-ischemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985;55:146.Google Scholar
  24. 24.
    Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986;314:1547.Google Scholar
  25. 25.
    Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303.Google Scholar
  26. 26.
    The CONSENSUS Trial Study Group. The effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429.Google Scholar
  27. 27.
    The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293.Google Scholar
  28. 28.
    Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G, for the V-HeFT VA Cooperative Studies Group. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. Circulation 1993;87:VI-24.Google Scholar
  29. 29.
    Kjerkshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990;65:I-42.Google Scholar
  30. 30.
    Stevenson LW, Fowler MB, Schroeder JS, Stevenson WG, Dracup KA, Fond V. Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Cardiol 1987;83:871.Google Scholar
  31. 31.
    Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993;88:2953.Google Scholar
  32. 32.
    Cosin J, Andrüs F, Hernandiz A, Solaz J, Bayés de Luna A. Different prevalence of sudden death in different countries. Cardiovasc Risk Factors 1991;1:194.Google Scholar
  33. 33.
    Bayés de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989;117:151.Google Scholar
  34. 34.
    Bayés de Luna A, Guindo J, Rivera I. Ambulatory sudden death. J Ambulat Monitoring 1989;2:3.Google Scholar
  35. 35.
    Bayés de Luna A, Guindo Soldevila J. Arritmias ventriculares espontaneas e inducidas por medicamentos en la ICCV. Significado pronìstico y tratamiento. En Iriarte Ezkurdia MM, Sagastagoitia Gorostiza JD. Insuficiencia Cardiaca Cínica. Barcelona, MCR, 1989.Google Scholar
  36. 36.
    Naccarelli GU, Prytowsky EN, Jackman WM, Heger JJ, Rahilly GT, Zipes DP. Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease. Am J Cardiol 1982;50:165.Google Scholar
  37. 37.
    Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME. Sustained ventricular tachycardia in patients with dilated cardiomyopathy. Electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 1984;70:451.Google Scholar
  38. 38.
    Poll DS, Marchlinski FE, Buxton AE, Josephson ME. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:992.Google Scholar
  39. 39.
    Rae AP, Spielman SR, Kutalek SP, Kay HR, Horowitz LN. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. Am J Cardiol 1987;59:291.Google Scholar
  40. 40.
    Stevenson WG, Stevenson LW, Weiss J, Tillisch JH. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J 1988; 116:1447.Google Scholar
  41. 41.
    Milner PG, Dimarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. PACE 1988;11:562.Google Scholar
  42. 42.
    Bing-Liem L, Swerdlow CD. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am J Cardiol 1988;62:611.Google Scholar
  43. 43.
    Carlson MD, Schoenfeld MH, Garan H, et al. Programmed ventricular stimulation in patients with left ventricular dysfunction and ventricular tachycardia: Effects of acute hemodynamic improvement due to nitroprusside. J Am Coll Cardiol 1989;14:1744.Google Scholar
  44. 44.
    Constantin L, Martins JB, Kienzle MG, Brownstein SL, McCue ML, Hopton RC. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy. PACE 1989;12:776.Google Scholar
  45. 45.
    Brembilla-Perrot B, Donetti J, Terrierde la Chaise A, Sadoul N, Juilliere Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991;121:1124.Google Scholar
  46. 46.
    Chen X, Shenasa M, Borggrefe M, Block M, Hidricks G, Martinez Rubio A, Haverkamp W, Willems S, Bôcker D, Mâkjârvi M, Breithardt G. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: Inducibility and prognostic value in 102 patients. Eur Heart J 1994;15:76.Google Scholar
  47. 47.
    Unverferth DV, Magorien RD, Moechsberger ML. Factors influencing one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147.Google Scholar
  48. 48.
    Bigger JT, Weld FM, Kleiger R, Miller JP, Rolnitzky LM, and the Multicenter Post-Infarction Research Group. The relationship between ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250.Google Scholar
  49. 49.
    Mukharjii J, Rude RE, Poole K, and the MILIS investigators. Risk factors for sudden death after acute myocardial infarction: Two-year follow-up. Am J Cardiol 1984;54:31.Google Scholar
  50. 50.
    Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson P, Cohn J, for the V-HeFT II VA Cooperative Studies Group. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. Circulation 1993;87:VI-49.Google Scholar
  51. 51.
    Parmley WW. Factors causing arrhythmias in chronic congestive heart failure. Am Heart J 1987;114:1267.Google Scholar
  52. 52.
    Taggart P, Sutton PMI, Treasure T, Lab M, O'Brien W, Runnalls M, Swanton RH, Emanuel RW. Monophasic action potentials at discontinuation of cardiopulmonary bypass: Evidence for contraction-excitation feedback in man. Circulation 1988;77:1266.Google Scholar
  53. 53.
    Gottlieb SS. Arrhythmias and sudden death in congestive heart failure. Current Opinion Cardiol 1989;4:368.Google Scholar
  54. 54.
    Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989;80:1675.Google Scholar
  55. 55.
    Swan HJC (ed). Meeting of the minds: Treatment of arrhythmias in congestive heart failure. Am Heart J 1987;114:1265.Google Scholar
  56. 56.
    Bigger JT. Management of ventricular arrhythmias in patients with congestive heart failure. Am J Cardiol 1986; 57:1B.Google Scholar
  57. 57.
    Meinertz T, Hofmann T, Hohnloser SH, Zehender M, Just H. Arrhythmias and left ventricular dysfunction. J Ambulat Monitoring 1989;2:66.Google Scholar
  58. 58.
    Cleland JGF, Dargie HJ. Arrhythmias, catecholamines and electrolytes. Am J Cardiol 1988;62:55A.Google Scholar
  59. 59.
    Parmley WW, Chatterjee K. Congestive heart failure and arrhythmias: An overview. Am J Cardiol 1986;57:34B.Google Scholar
  60. 60.
    Gomes JAC, Hariman RI, Kang PS, El-Sherif N, Chowder Lyons J. Programmed electrical stimulation in patients with high grade ventricular ectopy: Electrophysiological findings and prognosis for survival. Circulation 1984;70:43.Google Scholar
  61. 61.
    Wilson JR. Use of antiarrhythmic drugs in patients with heart failure: Clinical efficacy, hemodynamic results and relation to survival. Circulation 1987;75:IV-64.Google Scholar
  62. 62.
    Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: Electro-physiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 1984;70:451.Google Scholar
  63. 63.
    Meissner MC, Kay HR, Horowitz LN, Spielman SR, Greenspan AM, Kutalek SP. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Am J Cardiol 1988;61:1050.Google Scholar
  64. 64.
    Kuchar DL, Rottman J, Berger E, Freeman CS, Garan H, Ruskin JN. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study. J Am Coll Cardiol 1988;12:982.Google Scholar
  65. 65.
    Hohnloser SH, Raeder EA, Podrid PJ, Graboys TB, Lown B. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias. Am Heart J 1987;114:1.Google Scholar
  66. 66.
    Slater W, Lampert S, Podrid PJ, Lown B. Clinical predictors of arrhythmia worsening by antiarrhythmic drugs. Am J Cardiol 1988;61:349.Google Scholar
  67. 67.
    Rehnqvist N. Arrhythmias and their treatment in patients with heart failure. Am J Cardiol 1989;64:61J.Google Scholar
  68. 68.
    Flaker GC, Blackshear JL, McBride R, et al., on behalf of the Stroke Prevention in Atrial Fibrillation Investigators. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527.Google Scholar
  69. 69.
    Greene HL, Richardson DW, Hallstrom AP, et al. Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989;63:393.Google Scholar
  70. 70.
    Gottlieb SS. The use of antiarrhythmic agents in heart failure: Implications of CAST. Am Heart J 1989;118:1074.Google Scholar
  71. 71.
    Ravid S, Podrid PJ, Lambert S, Lown B. Congestive heart failure induced by six of the newer antiarrhythmic drugs. J Am Coll Cardiol 1989;14:1326.Google Scholar
  72. 72.
    Hamer AWF, Arkles LB, Johns JA. Beneficial effects of low dose amiodarone in patients with heart failure: A placebo controlled trial. J Am Coll Cardiol 1989;14:1768.Google Scholar
  73. 73.
    Neri R, Mestroni L, Salvi A, Pandullo C, Camerini F. Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone. Am Heart J 1987;113:707.Google Scholar
  74. 74.
    Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R, for Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493.Google Scholar
  75. 75.
    Singh SN, Fletcher RS, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al., for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77.Google Scholar
  76. 76.
    Waldo AL, Camm AJ, de Ruyter H, et al., for the SWORD Investigators. Preliminary mortality results from the survival with oral D-sotalol (SWORD) Trial. J Am Coll Cardiol 1995;25:15A.Google Scholar
  77. 77.
    The CASCADE Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol 1993;72:280.Google Scholar
  78. 78.
    Dominguez de Rozas JM, Garcia J, Guindo J, Oter R, Bayes de Luna A. Amiodarone as a drug of first choice in the prevention of sustained ventricular tachycardia and/or fibrillation. In Bayes de Luna A, Betriu A, Permanyer G. Cardiovascular Therapy. Martinus Nijhoff. Dordrecht, 1988.Google Scholar
  79. 79.
    Myers M, Peter T, Weiss D, et al. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: Minimum of three-year follow-up in 145 patients. Am Heart J 1990;119:8.Google Scholar
  80. 80.
    Olson PJ, Woelfel A, Simpson RJ, Foster JR. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. Am J Cardiol 1993;71:823.Google Scholar
  81. 81.
    Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. Mortality results. JAMA 1982;247:1707.Google Scholar
  82. 82.
    Chadda K, Goldstein S, Byington R, et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986;73:503.Google Scholar
  83. 83.
    Steinbeck G, Andersen D, Bach P, et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic sustained ventricular tachyarrhythmias. N Engl J Med 1992; 327:987.Google Scholar
  84. 84.
    CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765.Google Scholar
  85. 85.
    Packer M, Bristow MR, Cohn JN, et al., for the U.S. Carvedilol Heart Failure Study Group. The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349.Google Scholar
  86. 86.
    Kjerkshus JK. Importance of heart rate in determining beta-blocker effectiveness in acute long-term myocardial infarction trials. Am J Cardiol 1986;57:43F.Google Scholar
  87. 87.
    The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685.Google Scholar
  88. 88.
    Pfeffer MA, Braunwald E, Moyü LA, Basta L, Brown EJ, Cuddy TE, et al., on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669.Google Scholar
  89. 89.
    The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821.Google Scholar
  90. 90.
    Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al., for the Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:1670.Google Scholar
  91. 91.
    Guindo J, Bayes de Luna A, Torner P, Bartolucci J, Estiarte R. Treatment of heart failure: Impact on sudden death. In Bayes de Luna A, Brugada P, Cosin J, Navarro-Lopez F. Sudden Cardiac Death. Dordrecht, Kluwer Academic Publishers, 1991.Google Scholar
  92. 92.
    Fanarow G, Chellimsky-Fallick C, Stevenson LW, et al. Impact of vasodilator regimen on sudden death in advanced heart failure: A randomized trial of angiotensin-converting enzyme inhibition and direct vasodilation. J Am Coll Cardiol 1991;17:92A.Google Scholar
  93. 93.
    Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet therapy. Br Heart J 1988;296:320.Google Scholar
  94. 94.
    Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. New Engl J Med 1990;323:147.Google Scholar
  95. 95.
    Brooks R, Garan H, Smith PN, Ruskin JN. The role of cardiac surgery in the prevention of sudden death. In Kostis JB, Sanders M (eds). The Prevention of Sudden Cardiac Death. New York, Wiley-Liss, 1990; p. 221.Google Scholar
  96. 96.
    Holmes DR, Davis KB, Mock MB, et al. The effect of medical and surgical treatment on subsequent sudden death in patients with coronary artery disease: A report from the Coronary Artery Surgery Study. Circulation 1986;73:1254.Google Scholar
  97. 97.
    Stevenson LW, Miller LW. Cardiac transplantation as therapy for heart failure. Curr Prob Cardiol 1991;16:219.Google Scholar
  98. 98.
    Stevenson WG, Stevenson LW. The role of cardiac transplantation in sudden death prevention. In Josephson ME (ed). Sudden Cardiac Death. Oxford, Blackwell Sci Pub, 1993;356.Google Scholar
  99. 99.
    Saksena S. Nonpharmacologic therapy for malignant ventricular arrhythmias in patients with congestive heart failure. In Brachmann J, Dietz R, Kübler W (eds.) Heart Failure and Arrhythmias. Berlin, Springer-Verlag, 1990.Google Scholar
  100. 100.
    Holmes DR. The implantable cardioverter defibrillator. In Furman S, Haynes DL, Holmes DR. A Practice of Cardiac Pacing. Futura Publishing Company, Inc. Mount Kisko, NY, 1993:465–508.Google Scholar
  101. 101.
    Tchou P, Kadri N, Anderson J, et al. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 1988;109:529.Google Scholar
  102. 102.
    Axtell K, Tchou P, Akhtar M. Survival in patients with distressed left ventricular function treated by implantable cardioverter-defibrillator. PACE 1991;14:291.Google Scholar
  103. 103.
    Bôcker D, Block M, Isbruch F, Wietholt D, Hammel D, Borggrefe M, Breithardt G. Do patients with implantable defibrillators live longer? J Am Coll Cardiol 1993;21:1638.Google Scholar
  104. 104.
    Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannon DS, McGovern BA, et al. Influence of cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083.Google Scholar
  105. 105.
    Grimm W, Flores B, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter defibrillator therapy. Circulation 1993;87:1880.Google Scholar
  106. 106.
    Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, et al. Implantable transvenous cardioverter-defibrillators. Circulation 1993;87:1152.Google Scholar
  107. 107.
    The Cardiomyopathy Trial Investigators. Cardiomyopathy Trial. PACE 1993;16:576.Google Scholar
  108. 108.
    Magovern JA, Magovern GJ, Maher TD, et al. Operation for congestive heart failure: Transplantation, coronary bypass, and cardiomyoplasty. Ann Thorac Surg 1993;56:418.Google Scholar
  109. 109.
    Ostermeyer J, Breithardt G, Borggrefe M, et al. Direct operations for management of life-threatening ischemic ventricular tachycardia. J Thorac Cardiovasc Surg 1987;94:848.Google Scholar
  110. 110.
    Moran J, Kehoe R, Loeb J. Extended endocardial resection for the treatment of ventricular tachycardia. Ann Thorac Surg 1982;34:538.Google Scholar
  111. 111.
    Hargrove WC, Miller JM. Risk stratification and management of patients with recurrent ventricular tachycardia and other malignant ventricular arrhythmias. Circulation 1989; 79:I-178.Google Scholar
  112. 112.
    Breithardt G, Borggrefe M, Wietholt D, Isbruch F, Block M, Shenasa M, et al. Role of ventricular tachycardia surgery and catheter ablation as complements or alternatives to implantable cardioverter defibrillator in the 1990s. PACE 1992;15:681.Google Scholar
  113. 113.
    Morady F. Catheter ablation of ventricular tachycardia. In Josephson ME, Wellens HJJ (eds). Tachycardias: Mechanisms and Management. Futura Pub. Mount Kisco, New York, 1993:537.Google Scholar
  114. 114.
    Kim YH, Sosa-Suarez G, Trouton TG, et al. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation 1994;89:1094.Google Scholar
  115. 115.
    Rabbani LE, Wang PJ, Couper GL, Friedman PL. Time course of improvement in ventricular function after ablation of incessant automatic atrial fibrillation. Am Heart J 1991;121:816.Google Scholar
  116. 116.
    Chen SA, Yang CJ, Chiang CE, et al. Reversibility of left ventricular dysfunction after successful catheter ablation of supraventricular reentrant tachycardia. Am Heart J 1992; 124:1512.Google Scholar
  117. 117.
    Zehender M, Buchner C, Meinertz T, et al. Prevalence, circumstances, mechanisms and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing. Circulation 1992;85:596.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • J. Guindo
    • 1
  • A. Bayés Genis
    • 1
  • J. M. Dominguez de Rozas
    • 1
  • M. Fiol
    • 2
  • X. Vinolas
    • 1
  • A. Bayés de Luna
    • 1
  1. 1.Department of CardiologyHospital de Sant Pa BarcelonaSpain
  2. 2.Coronary Care UnitHospital de Son DuretaPalma de MallorcaSpain

Personalised recommendations